Anchor Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Anchor Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $4,357 - $4,798	-60 Reduced 2.15%	2,731 $210,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $171,590 - $205,752	2,791 New	2,791 $204,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $175,438 - $254,952	-3,781 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $186,063 - $242,702	3,781 New	3,781 $243,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Capital Advisors LLC with notifications on news.